Screener
TG Therapeutics TGTX Total Revenue
Total Revenue at other companies
Segments
By product
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: TG Therapeutics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025955
| Line item | Three months ended / June 30, 2026 | Three months ended / June 30, 2025 | Six months ended / June 30, 2026 | Six months ended / June 30, 2025 |
|---|---|---|---|---|
| Revenue: | ||||
| Product revenue, net | $235,794 | $138,843 | $437,102 | $258,498 |
| License, milestone, royalty and other revenue | 4,541 | 2,305 | 8,151 | 3,506 |
| Total revenue | $240,335 | $141,148 | $445,253 | $262,004 |
| Costs and expenses: | ||||
| Cost of revenue | 41,194 | 18,938 | 74,704 | 34,479 |
| Research and development: | ||||
| Stock-based compensation | 8,070 | 4,318 | 12,945 | 7,649 |
Document
FAQ
- What is TG Therapeutics's total revenue?
- TG Therapeutics (TGTX) reported total revenue of $240.34M in Q2 2026.
- How has TG Therapeutics's total revenue changed year-over-year?
- TG Therapeutics's total revenue increased by 70.3% year-over-year, from $141.15M to $240.34M.
- What is the long-term trend for TG Therapeutics's total revenue?
- Over 4 years (2021 to 2025), TG Therapeutics's total revenue has grown at a 209.8% compound annual growth rate (CAGR), from $6.69M to $616.29M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about TG Therapeutics's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude